Strategic Information for the Life Science and Analytical Instrument Industry
Established in 2005, IonSense is the only company to offer DART (Direct Analysis in Real Time) technology. DART, and its newest iteration, DART JumpShot, are open-air ambient ionization sources for mass spectrometry (MS). DART is able to analyze samples in their native states at atmospheric pressure without sample contact. Based in Massachusetts, the company currently […]
In its latest major product introduction, announced last month, Agilent Technologies has expanded its line of InfinityLab Bio liquid chromatography (LC) systems. With a sample flow path containing biocompatible materials, the Bio LC portfolio addresses issues such as corrosion and leaching arising from protein interactions with traditional flow path materials such as iron. The portfolio […]
SCIEX (a Danaher company), one of the world’s largest mass spectrometry (MS) companies, has introduced a new QTOF MS platform. The ZenoTOF 7600 LC-MS/MS is the company’s latest QTOF system, joining a QTOF product portfolio that includes the TripleTOF series and X500 models. Strategic Directions International (SDi) estimates worldwide QTOF MS demand to exceed $400 […]
In a recently published report, Strategic Directions International (SDi), IBO’s publisher, provides an overview of the fast-growing Chinese analytical instrument and lab product market. The report, “China 2021: The Market for Laboratory Analytical & Life Science Instruments,” includes forecast and market segmentation details for ten categories of laboratory technologies (see below). China’s investment in R&D, […]
As one of the fastest growing segments of the biopharma market, cell and gene therapies (CGT) are creating a new era of medical treatments. Making cell and gene therapies possible are genetic manipulation and cell growth and maintenance. To accomplish these tasks in R&D, quality control and manufacturing, scientists are drawing on established laboratory tools […]
A new report from the US Congressional Budget Office (CBO) provides a snapshot of the US pharmaceutical industry and its R&D patterns. The report also explains the important role that the federal government plays in drug development and sales. Here, IBO gives an overview of the data presented in the report on pharmaceutical sales and […]
Bioprocessing International (BPI) US West 2021 kicked off its virtual edition this morning, Monday March 29. An annual event, BPI West encompasses presentation, posters and networking events focused on the latest developments in bioprocessing and cell and gene therapy. A talk this morning, “Integration of Paperless Benchtop Instruments in Clinical Manufacturing,” presented by Simon Barskyi […]
The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]
Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]
